Matthew W. Foehr - 13 May 2022 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Signature
By: Charles S. Berkman For: Matthew W. Foehr
Issuer symbol
LGND
Transactions as of
13 May 2022
Net transactions value
+$206,910
Form type
4
Filing time
13 May 2022, 19:05:42 UTC
Previous filing
09 May 2022
Next filing
14 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Purchase $206,910 +2,500 +1.5% $82.76 173,354 13 May 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.